Target intelligence / Profile preview

Guanylate cyclase soluble subunit alpha-2 (GC-SA2)

Target
GC-SA2
Molecular classification
Enzyme
01

Overview

Guanylate cyclase soluble subunit alpha-2 is a component of the soluble guanylyl/guanylate cyclase (sGC) enzyme complex. sGC catalyzes the conversion of GTP to cyclic GMP (cGMP) in response to nitric oxide (NO) signaling. cGMP acts as a second messenger involved in various physiological processes including vasodilation, smooth muscle relaxation, platelet aggregation inhibition, and neurotransmission. Dysregulation or mutations affecting sGC function have implications in cardiovascular diseases. Pharmacological activators/stimulators targeting sGC are being explored for therapeutic use.

Other names
GUCY1A2GUC1A2guanylate cyclase 1, soluble, alpha 2
02

Mechanism of action

sGC stimulators activate the enzyme to increase cGMP production.

03

Biological functions

Signal transductionVasodilationSmooth muscle relaxationPlatelet aggregation inhibitionNeurotransmissioncGMP production
04

Disease associations

Cardiovascular diseaseHypertensionHeart failure

Beyond the preview

Go deeper on Guanylate cyclase soluble subunit alpha-2 (GC-SA2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Guanylate cyclase soluble subunit alpha-2 (GC-SA2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call